Regulatory Nucleic Acid Molecules for Enhancing Constitutive Gene Expression in Plants
AssigneeBASF Plant Science GmbH
InventorsJulia Verena Hartig, Maarten Hendrik Stuiver, Josef Martin Kuhn, Alrun Nora Burgmeier
Life of this patent
Estimating the term…
Abstract
The present invention is in the field of plant molecular biology and provides methods for production of high expressing constitutive promoters and the production of plants with enhanced constitutive expression of nucleic acids wherein nucleic acid expression enhancing nucleic acids (NEENAs) are functionally linked to said promoters and/or introduced into plants.
Claims19
A method for production of a high expression constitutive plant promoter comprising functionally linking to a promoter one or more nucleic acid expression enhancing nucleic acids (NEENA) heterologous to said promoter comprising:
- i) a nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 and 14958 to 14960;
- or
- ii) a nucleic acid molecule having a sequence with an identity of at least 80% to a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iii) a fragment of 100 or more consecutive bases of a nucleic acid molecule of i) or ii) which has at least 65% or more expression enhancing activity as the corresponding nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iv) a nucleic acid molecule which is the complement or reverse complement of any of the previously mentioned nucleic acid molecules under i) or ii);
- or
- v) a nucleic acid molecule hybridizing under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50° C. with washing in 2×SSC, 0.1% SDS at 50° C. to a nucleic acid molecule comprising at least 50 consecutive nucleotides of a transcription enhancing nucleotide sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960.
A method for producing a plant or part thereof with, compared to a respective control plant or part thereof, enhanced constitutive expression of one or more nucleic acid molecule comprising the steps of:
- a) introducing into the plant or part thereof one or more NEENA comprising:
- i) a nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 and 14958 to 14960;
- or
- ii) a nucleic acid molecule having a sequence with an identity of at least 80% to a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iii) a fragment of 100 or more consecutive bases of a nucleic acid molecule of i) or ii) which has at least 65% or more expression enhancing activity as the corresponding nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iv) a nucleic acid molecule which is the complement or reverse complement of any of the previously mentioned nucleic acid molecules under i) or ii);
- or
- v) a nucleic acid molecule hybridizing under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50° C. with washing in 2×SSC, 0.1% SDS at 50° C. to a nucleic acid molecule comprising at least 50 consecutive nucleotides of a transcription enhancing nucleotide sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- and
- b) functionally linking said one or more NEENA to a constitutive promoter and to a nucleic acid molecule being under the control of said constitutive promoter, wherein the NEENA is heterologous to said nucleic acid molecule.
A recombinant expression construct comprising one or more NEENA comprising:
- i) a nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 and 14958 to 14960;
- or
- ii) a nucleic acid molecule having a sequence with an identity of at least 80% to a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iii) a fragment of 100 or more consecutive bases of a nucleic acid molecule of i) or ii) which has at least 65% or more expression enhancing activity as the corresponding nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iv) a nucleic acid molecule which is the complement or reverse complement of any of the previously mentioned nucleic acid molecules under i) or ii);
- or
- v) a nucleic acid molecule hybridizing under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50° C. with washing in 2×SSC, 0.1% SDS at 50° C. to a nucleic acid molecule comprising at least 50 consecutive nucleotides of a transcription enhancing nucleotide sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960.
A transgenic plant or part thereof:
- i) a nucleic acid molecule having a sequence selected from SEQ ID NOS:
- I to 14937 and 14958 to 14960;
- or
- ii) a nucleic acid molecule having a sequence with an identity of at least 80% to a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iii) a fragment of 100 or more consecutive bases of a nucleic acid molecule of i) or ii) which has at least 65% or more expression enhancing activity as the corresponding nucleic acid molecule having a sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960;
- or
- iv) a nucleic acid molecule which is the complement or reverse complement of any of the previously mentioned nucleic acid molecules under i) or ii);
- or
- v) a nucleic acid molecule hybridizing under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50° C. with washing in 2×SSC, 0.1% SDS at 50° C. to a nucleic acid molecule comprising at least 50 consecutive nucleotides of a transcription enhancing nucleotide sequence selected from SEQ ID NOS:
- 1 to 14937 or 14958 to 14960.
(canceled)
(canceled)
Dependencies are inferred from the claim text.